Israeli study finds Pfizer vaccine 95% effective against COVID-19

Israeli HMO Maccabi, which covers over a quarter of all Israelis, said in a statement that only 608 people had tested positive for COVID-19 more than a week after receiving the second of two required Pfizer doses. The comparison was against a group of 528,000 Israelis with similar backgrounds who did not receive the vaccine, Maccabi said.

Reuters | Tel Aviv | Updated: 17-02-2021 21:32 IST | Created: 17-02-2021 21:29 IST
Israeli study finds Pfizer vaccine 95% effective against COVID-19
Representative image

An Israeli healthcare provider said on Wednesday that Pfizer Inc's COVID-19 vaccine was 95% effective in a trial of 602,000 people, reinforcing the drugmaker's efficacy findings. Israeli HMO Maccabi, which covers over a quarter of all Israelis, said in a statement that only 608 people had tested positive for COVID-19 more than a week after receiving the second of two required Pfizer doses.

The comparison was against a group of 528,000 Israelis with similar backgrounds who did not receive the vaccine, Maccabi said. Of those, 20,621 tested positive. "By comparing the proportion of new cases between the vaccinated and yet-to-be vaccinated groups, efficacy of the vaccine in Israel is currently estimated at 95%, seven or more days after receiving the second dose," Maccabi said.

Most of the 608 infected vaccinees reported only mild symptoms, such as a headache or cough, Maccabi said. Some 21 required hospitalisation, seven of whom had severe symptoms, it added. The data by Maccabi reinforces efficacy findings by Pfizer and its German partner BioNTech, which following a late-stage trial also found their vaccine to be 95% effective.

Nearly 44% of Israel's 9.1 million citizens have received at least one shot of the Pfizer vaccine, making the country the largest real-world study of its efficacy. On Wednesday, Clalit, Israel's largest healthcare provider, reported a 94% drop in symptomatic COVID-19 cases among 600,000 people who had received both Pfizer doses.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

East African women traders: 'Celebrating the past, planning for the future'

COVID-19 has hit women disproportionately hard across East Africa, especially those working in the informal sector. Lessons must be learnt to prevent this from happening again....

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

Videos

Latest News

China has far greater nuclear capacity than thought: Top US Commander

The United States has only learned in the past week that China has developed a fast breeder capacity allowing it to make far more plutonium nuclear warheads than US assessments had previously thought possible, according to a top US Commande...

HC orders Centre to ensure oxygen supply to Delhi, says govt can make 'heaven and earth meet' if they want

The Delhi High Court on Thursday asked the Centre to implement its order strictly for allocating medical oxygen to the national capital and ensuring a safe passage to oxygen without facing any obstruction. A Division Bench of Justices Vipin...

PTI tally of COVID-19 cases, recoveries and deaths in India at 10.20 pm

Following is a stateUnion Territory-wise tally of COVID-19 cases, active cases, recoveries and deaths in India at 10.20 pm, according to data provided by various governments.NORTHERN REGION StateUT Confirmed Discharged Deaths Active -------...

France may grant early COVID vaccine access to obese people, says minister

French Health Minister Olivier Veran said on Thursday the authorities were considering granting early access to COVID-19 vaccine to people suffering from obesity, adding that this should be put in place starting from mid-May.During a news c...

Give Feedback